Kyoung-Mee Kim Selected Research

SAIT301

1/2018

Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyoung-Mee Kim Research Topics

Disease

134	Neoplasms (Cancer) 09/2022 - 02/2005
100	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2008
29	Microsatellite Instability 05/2022 - 01/2002
19	Carcinoma (Carcinomatosis) 01/2022 - 02/2005
17	Adenocarcinoma 01/2021 - 09/2005
17	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 02/2002
9	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2009
9	Carcinogenesis 01/2020 - 01/2006
8	Lymphatic Metastasis 01/2021 - 12/2008
8	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2016 - 11/2006
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016 - 09/2005
6	Breast Neoplasms (Breast Cancer) 05/2013 - 08/2006
5	Adenoma (Adenomas) 01/2018 - 02/2005
4	Ascites 01/2018 - 01/2013
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 10/2012
3	Turcot syndrome 10/2021 - 09/2017
3	Sarcopenia 03/2021 - 11/2020
3	Lymphoma (Lymphomas) 01/2021 - 01/2008
3	Melanoma (Melanoma, Malignant) 01/2021 - 06/2011
3	Hypoxia (Hypoxemia) 01/2021 - 02/2016
3	Polyps 01/2012 - 05/2010
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 08/2011 - 12/2008
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2009 - 01/2006
3	B-Cell Lymphoma (Lymphoma, B Cell) 02/2009 - 01/2006
2	Adenocarcinoma of Lung 06/2020 - 01/2016
2	Disease Progression 01/2020 - 12/2013
2	Signet Ring Cell Carcinoma 05/2018 - 12/2008
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2017
2	Necrosis 06/2017 - 06/2010
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2017 - 11/2015
2	Epstein-Barr Virus Infections 07/2016 - 01/2009

Drug/Important Bio-Agent (IBA)

33	Biomarkers (Surrogate Marker)IBA 09/2022 - 08/2009
21	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
12	ParaffinIBA 01/2022 - 01/2008
12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
11	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2018
10	Phosphotransferases (Kinase)IBA 01/2022 - 06/2011
10	B7-H1 AntigenIBA 09/2021 - 01/2016
10	Biological ProductsIBA 01/2020 - 12/2008
9	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2017
9	Formaldehyde (Formol)FDA Link 01/2022 - 01/2012
8	Capecitabine (Xeloda)FDA Link 12/2018 - 07/2011
6	pembrolizumabIBA 01/2021 - 01/2018
6	AntibodiesIBA 01/2021 - 04/2012
6	Monoclonal AntibodiesIBA 01/2019 - 12/2013
6	Calcibiotic Root Canal SealerIBA 03/2017 - 02/2002
6	Imatinib Mesylate (Gleevec)FDA Link 10/2013 - 06/2008
5	NucleotidesIBA 01/2021 - 07/2002
5	Cell-Free Nucleic AcidsIBA 01/2020 - 11/2015
5	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 06/2010
5	Trastuzumab (Herceptin)FDA Link 03/2015 - 05/2013
4	PlatinumIBA 01/2022 - 01/2012
4	human ERBB2 proteinIBA 01/2022 - 12/2014
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
4	Small Interfering RNA (siRNA)IBA 12/2019 - 12/2011
4	S100 Proteins (S 100 Protein)IBA 09/2016 - 11/2006
4	Everolimus FDA Link 01/2016 - 07/2011
4	MucinsIBA 01/2013 - 09/2005
4	Cyclin D1IBA 08/2009 - 01/2008
3	EnzymesIBA 01/2021 - 01/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2014
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 08/2015
3	Simvastatin (Zocor)FDA LinkGeneric 03/2020 - 06/2014
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2008
3	Leucovorin (Folinic Acid)FDA Link 01/2020 - 01/2008
3	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2020 - 04/2019
3	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 01/2017
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2017 - 04/2015
3	Anaplastic Lymphoma KinaseIBA 01/2016 - 05/2013
3	tyrosine receptor (receptor, tyrosine)IBA 12/2015 - 05/2013
3	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2009 - 01/2006
2	ceralasertibIBA 01/2022 - 01/2021
2	RamucirumabIBA 01/2021 - 01/2019
2	NivolumabIBA 01/2021 - 06/2020
2	LigandsIBA 04/2020 - 02/2017
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020 - 03/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2019 - 05/2013
2	Neutralizing AntibodiesIBA 01/2019 - 01/2015
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2019 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2018 - 02/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 07/2016
2	c-Mer Tyrosine KinaseIBA 12/2017 - 11/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2017 - 01/2016
2	Protein Isoforms (Isoforms)IBA 01/2017 - 01/2016
2	CollagenIBA 09/2016 - 10/2012

Therapy/Procedure

38	Therapeutics 01/2021 - 01/2008
21	Drug Therapy (Chemotherapy) 01/2022 - 08/2006
19	Gastrectomy 12/2021 - 04/2008
18	Immunotherapy 02/2022 - 02/2016
9	Adjuvant Chemotherapy 10/2020 - 08/2006
8	Radiotherapy 01/2021 - 01/2012
6	Adjuvant Chemoradiotherapy 04/2020 - 10/2015
6	Chemoradiotherapy 04/2020 - 01/2012
5	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2012
3	Precision Medicine 01/2018 - 06/2011
3	Aftercare (After-Treatment) 01/2016 - 08/2009
3	Surgical Instruments (Clip) 10/2014 - 01/2011
2	Molecular Targeted Therapy 10/2016 - 12/2008